Search results
IBD 50 Stocks To Watch: Biotech Leader Intra-Cellular Therapies Is Breaking Out Past A New Buy Point
Investor's Business Daily· 6 months agoBiotech leader Intra-Cellular Therapies, Wednesday's pick for IBD 50 Growth Stocks To Watch, is...
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
Motley Fool via Yahoo Finance· 22 hours agoEven if you're not an investor like Cathie Wood, who specializes in businesses that claim to have a...
Biotech's Blockbuster Week: 3 Stocks to Watch
Zacks via Yahoo Finance· 1 year agoThis week, biotech was a standout performer. As of Friday morning, the SPDR S&P Biotech ETF XBI delivered gains of 6.42% versus gains of 1.79%. Last year...
Biotech Stock United Therapeutics Revives Breakout, Retakes Buy Zone
Investor's Business Daily· 2 years agoAfter breaking out to a new high last month then pulling back, United Therapeutics has revived its...
12 Best Biotech Stocks to Buy Under $10
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we discuss the 12 best biotech stocks to buy under $10. If you want to see more stocks in this selection, check out 5 Best Biotech...
Biotech Stocks Embrace The Neuroscience Renaissance With Biogen, Amylyx At The Helm
Investor's Business Daily· 2 years agoThe complexities of the human brain have perplexed drugmakers for years, but a slew of recent...
Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
Investor's Business Daily· 1 year agoPeople have griped about prescription drug prices for years. Soon, Medicare plans to do something...
Zacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals,...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – November 24, 2023 – Today, Zacks Equity Research discusses...
3 Biotech Stocks to Make Your ‘Get Rich’ Dreams Come True
InvestorPlace via Yahoo Finance· 11 months agoNavigating the choppy waters in the biotech sphere can be daunting, which makes it a challenge to...
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology
Zacks via Yahoo Finance· 4 months agoFor Immediate Release Chicago, IL – February 14, 2024 – Today, Zacks Equity Research discusses...
